"
Team:Hong Kong HKUST/protocols
From 2013.igem.org
(Difference between revisions)
| Line 209: | Line 209: | ||
<div id="1" class="slide"><a href=""><h3>GC-MS</h3><br></a></div> | <div id="1" class="slide"><a href=""><h3>GC-MS</h3><br></a></div> | ||
<div id="1" class="slide"><a href=""><h3>Fatty Acid Treatment</h3></a><br></div> | <div id="1" class="slide"><a href=""><h3>Fatty Acid Treatment</h3></a><br></div> | ||
| - | <div id="1" class="slide"><a href=""><h3>PDRIVE-HGRP78</h3></a><br></div> | + | <div id="1" class="slide"><a href=""><h3>PDRIVE-HGRP78</h3></a><br></div> |
<div id="1" class="slide"><a href=""><h3>Mitotracking Dye</h3></a><br></div> | <div id="1" class="slide"><a href=""><h3>Mitotracking Dye</h3></a><br></div> | ||
<div id="1" class="slide"><a href=""><h3>Lipofectamine® 2000</h3></a><br></div> | <div id="1" class="slide"><a href=""><h3>Lipofectamine® 2000</h3></a><br></div> | ||
Revision as of 12:11, 26 September 2013
